Acquisition boosts Symyx Research Services in Life Sciences and expands offering into Biologic Formulations

21-Aug-2008 - USA

Symyx Technologies, Inc. has announced the acquisition of Integrity Biosolution, LLC in an all-cash transaction. IntegrityBio offers contract formulation research and analytical services, providing formulation and stability solutions for large molecule biopharmaceuticals along with Good Manufacturing Practices (GMP) fill/finish services for Phase I and II clinical trial volumes. Specific terms of the acquisition were not disclosed.

The acquisition expands Symyx's Research Service offerings in life sciences into biologic formulations, complementing its existing chemical formulations services. According to the company, the combination of Symyx and IntegrityBio creates a differentiated set of large molecule formulation services to customers in the pharmaceutical and biotechnology industries by combining IntegrityBio's formulation expertise with Symyx's advanced high-throughput research and informatics capabilities.

Other news from the department business & finance

These products might interest you

HUMIPLATE

HUMIPLATE by ACARYON

Get new insights on the health promoting properties of your product(s)

Customized Studies – Tailored to Your Needs

contract analysis
Genomics & Analytical Services

Genomics & Analytical Services by Azenta

Integrated Genomics & Analytical Services from Azenta Life Sciences

Discovery can be challenging work. Until you find the right genomics partner.

analytical services
Loading...

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?